Janux Selects Doses for Phase 1b Trials of JANX007 in mCRPC Following Positive Phase 1a Results

Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biopharmaceutical company developing innovative immunotherapies, announced positive interim clinical data for its JANX007 program in metastatic castration-resistant prostate cancer (mCRPC). The company will host a virtual event today at 4:30 PM ET to…

Read MoreJanux Selects Doses for Phase 1b Trials of JANX007 in mCRPC Following Positive Phase 1a Results

Radiology Partners and RADPAIR Form Strategic Partnership for Generative AI in Radiology

Radiology Partners (RP), the leading radiology practice in the U.S., and RADPAIR, a leader in generative AI-driven radiology solutions, have announced a strategic partnership aimed at advancing innovation in radiology and tackling critical capacity challenges. The collaboration will focus on…

Read MoreRadiology Partners and RADPAIR Form Strategic Partnership for Generative AI in Radiology

Hologic Presents Research on Breast Imaging AI’s Consistent Performance Across Diverse Populations

Hologic, Inc. (Nasdaq: HOLX) presented new research at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), showcasing the performance of its Genius AI® Detection 2.0 software across diverse patient populations. Artificial intelligence (AI)…

Read MoreHologic Presents Research on Breast Imaging AI’s Consistent Performance Across Diverse Populations

Mission Bio Partners with University of Miami Researchers to Accelerate Early Relapse Detection in Multiple Myeloma

Mission Bio, a leader in single-cell multiomics for precision medicine, has announced a collaboration with Dr. C. Ola Landgren, MD, PhD, director of a renowned myeloma research laboratory. Dr. Landgren, along with Dr. David Coffey and Dr. Benjamin Diamond from…

Read MoreMission Bio Partners with University of Miami Researchers to Accelerate Early Relapse Detection in Multiple Myeloma

Positive CHMP Opinion for Palforzia® to Treat Toddlers with Peanut Allergy

Stallergenes Greer, a biopharmaceutical company specializing in allergen immunotherapy (AIT), has announced a significant milestone with the positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). The recommendation is for the…

Read MorePositive CHMP Opinion for Palforzia® to Treat Toddlers with Peanut Allergy

Maverick Medical AI Completes Real-Time Autonomous Medical Coding Implementation at RadNet

Maverick Medical AI has announced the successful deployment of its real-time, AI-powered autonomous medical coding solution at all 399 RadNet, Inc. (NASDAQ: RDNT) locations. RadNet is a national leader in delivering high-quality, cost-effective outpatient diagnostic imaging services. RadNet has successfully…

Read MoreMaverick Medical AI Completes Real-Time Autonomous Medical Coding Implementation at RadNet

Life Healthcare Reports Strong H2-2024 Performance and Robust International Sales

Life Healthcare delivered a strong performance in the second half of 2024, particularly in its acute and complementary healthcare businesses in southern Africa. Acute hospital patient volumes showed positive growth, with paid patient days (PPDs) increasing by 1.6%. Occupancy rates…

Read MoreLife Healthcare Reports Strong H2-2024 Performance and Robust International Sales